Jetzt kostenlos testen

The Value of Everything

Who Makes and Who Takes from the Real Economy
Sprecher: Randye Kaye
Spieldauer: 12 Std. und 28 Min.
3.5 out of 5 stars (2 Bewertungen)

Danach 9,95 € pro Monat. Jederzeit kündbar.

ODER
Im Warenkorb

Inhaltsangabe

The Value of Everything argues that American companies have for too long been valued according to the amount of wealth they capture for themselves rather than for the value they create for the economy. In fact, Pfizer, Amazon, and other companies are actually dependent on public money, spend their resources on boosting share prices and executive pay, and reap ever-expanding rewards without offering the market value. 

In her previous work, The Entrepreneurial State, Mariana Mazzucato argued that public investment has been the most significant driver of innovation and product development. The iPhone as it exists would not have been possible without government-sponsored technology like Siri and Touch ID. Yet Apple today, like numerous other companies, is engaging in a massive repurchase scheme, and for the first time has prioritized value-extraction practices such as spending to boost shareholder profit-the very initiatives that funded their software. If private companies continue down this path, they will succeed in diminishing the size of their largest and most successful investor - the state - and will destroy powerful opportunities, shrivel markets, and depress wealth.

©2018 Mariana Mazzucato (P)2018 HighBridge, a division of Recorded Books

Hörerrezensionen

Bewertung

Gesamt

  • 3.5 out of 5 stars
  • 5 Sterne
    0
  • 4 Sterne
    1
  • 3 Sterne
    1
  • 2 Sterne
    0
  • 1 Stern
    0

Sprecher

  • 3 out of 5 stars
  • 5 Sterne
    1
  • 4 Sterne
    0
  • 3 Sterne
    0
  • 2 Sterne
    0
  • 1 Stern
    1

Geschichte

  • 4.5 out of 5 stars
  • 5 Sterne
    1
  • 4 Sterne
    1
  • 3 Sterne
    0
  • 2 Sterne
    0
  • 1 Stern
    0
Sortieren nach:
  • Gesamt
    3 out of 5 stars
  • Sprecher
    1 out of 5 stars
  • Geschichte
    4 out of 5 stars

A few good thoughts, not a must read for most people

Lengthy at times, mechanical voice certainly didn’t help.
A couple of very good thoughts, questions, and insights= 5 stars; unfortunately also a couple pf poor sections that appeared dogmatic, e.g. on share buybacks; I prefer Warren Buffett’s perspective on the topic. Other sections that were biased include drug pricing and venture capital.
Pharmaceutical development and venture capitalism usually involve a lot of risk, hence, require a substantial reward in case of success. If failure is privatized, success cannot be socialized. The opposite holds true, as well.
Overall, a qualified recommendation for people with this particular interest; I learned a few things on national accounting.